NCT05563350View on ClinicalTrials.gov

Metabolism of Chlordiazepoxide in the Treatment of Alcohol Withdrawal Symptoms

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

January 29, 2022

Primary Completion Date

June 11, 2023

Study Completion Date

July 1, 2023

Conditions
Alcohol Withdrawal
Interventions
DIAGNOSTIC_TEST

Blood samples

p-chlordiazepoxide and metabolites, p-omeprazole and metabolites, p-midazolam and metabolites, CYP3A4 and CYP2C19 genotyping

Trial Locations (1)

2400

Bispebjerg and Frederiksberg Hospital, Copenhagen

All Listed Sponsors
lead

University Hospital Bispebjerg and Frederiksberg

OTHER